Search Results - "Kondakci, M"

Analysis of the impact of adherence to guidelines and expert advice in patients with myelodysplastic syndromes by Kasprzak, A., Nachtkamp, K., Kondakci, M., Schroeder, T., Kobbe, G., Kündgen, A., Kaivers, J., Rautenberg, C., Haas, R., Gattermann, N., Bonadies, N., Germing, U.

“…The European Leukemia Net (ELN) guidelines for treatment of myelodysplastic syndromes (MDS) connect heterogeneous MDS subgroups with a number of therapeutic…”
Get full text

S106: UBTF‐ATXN7L3 GENE FUSION DUE TO 17Q21.31 DELETION DEFINES NOVEL HIGH‐RISK ALL SUBTYPE AMENABLE TO MRD‐BASED TREATMENT INTENSIFICATION by Bastian, L., Hartmann, A., Beder, T., Hänzelmann, S., Kässens, J., Bultmann, M., Höppner, M. P., Franzenburg, S., Wittig, M., Franke, A., Nagel, I., Spielmann, M., Reimer, N., Busch, H., Schwartz, S., Steffen, B., Viardot, A., Döhner, K., Kondakci, M., Wulf, G., Wendelin, K., Renzelmann, A., Kiani, A., Trautmann, H., Neumann, M., Gökbuget, N., Brüggemann, M., Baldus, C.

Get full text

245 CHOICE OF THERAPY HAS THE STRONGEST IMPACT ON SURVIVAL IN OLDER ADULTS WITH ACUTE MYELOID LEUKEMIA OR AML AFTER MYELODYSPLASTIC SYNDROME by Rumcheva, I, Schemenau, J, Hildebrandt, B, Kündgen, A, Schroeder, T, Kondakci, M, Kobbe, G, Haas, R, Germing, U

Get full text

A 3-day short course of palifermin before HDT reduces toxicity and need for supportive care after autologous blood stem-cell transplantation in patients with multiple myeloma by Kobbe, G., Bruns, I., Schroeder, T., Czibere, A., Warnecke, J., Hieronimus, N., Safaian, N., Kondakci, M., Saure, C., Germing, U., Haas, R., Fenk, R.

“…We retrospectively determined whether a 3-day short course of palifermin could reduce the toxicity of high-dose therapy (HDT) and autologous blood stem-cell…”
Get full text

Tacrolimus and mycofenolate mofetil as GvHD prophylaxis following nonmyeloablative conditioning and unrelated hematopoietic SCT for adult patients with advanced hematologic diseases by Zohren, F, Schroeder, T, Czibere, A, Fenk, R, Bruns, I, Kondakci, M, Saure, C, Haas, R, Kobbe, G

“…In the current study, we evaluated a combination of tacrolimus and mycophenolate mofetil (MMF) as GvHD prophylaxis in 50 patients undergoing truly…”
Get full text

121 PERIPHERAL BLOOD (PB) WILMS' TUMOR 1 (WT1) EXPRESSION QUANTIFIED BY A STANDARDIZED EUROPEAN LEUKEMIA NET (ELN)-CERTIFIED ASSAY AS PROGNOSTIC AND MINIMAL RESIDUAL DISEASE (MRD) MARKER IN MDS by Schroeder, T, Pechtel, S, Lamers, M, Dienst, A, Schuler, E, Rachlis, E, Wegener, N, Kündgen, A, Kondakci, M, Fenk, R, Haas, R, Germing, U, Kobbe, G

Get full text

Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma by STEIDL, U, FENK, R, HAAS, R, KOBBE, G, BRUNS, I, NEUMANN, F, KONDAKCI, M, HOYER, B, GRÄF, T, ROHR, U-P, BORK, S, KRONENWETT, R

“…Following induction therapy and 4 g/m(2) cyclophosphamide, a single dose of 12 mg polyethyleneglycol-conjugated G-CSF (pegfilgrastim; n=12) or daily doses of…”
Get full text

Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma by Fenk, R, Hoyer, B, Steidl, U, Kondakci, M, Graef, T, Heuk, R, Ruf, L, Strupp, C, Neumann, F, Rohr, U-P, Hildebrandt, B, Haas, R, Kobbe, G

Get full text

Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia by Kobbe, G., Fenk, R., Neumann, F., Bernhardt, A., Steidl, U., Kondakci, M., Graef, T., Aivado, M., Vaupel, M., Huenerlituerkoglu, A.-N., Kronenwett, R., Pape, H., Hildebrand, B., Germing, U., Haas, R.

“…The aim of this study was to investigate preservation of anti-leukemic activity and protection from opportunistic infections after transplantation of…”
Get full text

Favourable Outcome of Elderly Patients with Multiple Myeloma Treated with Tandem Melphalan 100 High-Dose Therapy, Autologous Stem Cell Transplantation and Novel Agents - a Single Center Experience by Neukirchen, Judith, Arat, Pia, Teutloff, Charlotte, Gerrlich, Celina, Lopez y Niedenhoff, David, Boquoi, Amelie, Savickaite, Ingrida, Dienst, Ariane, Nachtkamp, Kathrin, Gattermann, Norbert, Schroeder, Thomas, Kondakci, Mustafa, Kobbe, Guido, Haas, Rainer, Fenk, Roland

“…▪ Introduction: High-dose therapy (HDT) with autologous peripheral blood (PB) stem cell transplantation (SCT) is currently standard of care in patients with…”
Get full text

Myelodysplastische Syndrome by Rautenberg, C, Kondakci, M, Nusch, A, Kaivers, J, Götze, K, Haas, R, Schroeder, T, Germing, U

“…Bei den myelodysplastischen Syndromen (MDS) handelt es sich um klonale Erkrankungen der hämatopoetischen Stammzelle, welche typischerweise mit…”
Get full text

Myelodysplastische Syndrome: Diagnostik und Therapie by Rautenberg, C., Kondakci, M., Nusch, A., Kaivers, J., Götze, K., Haas, R., Schroeder, T., Germing, U.

“…Zusammenfassung Bei den myelodysplastischen Syndromen (MDS) handelt es sich um klonale Erkrankungen der hämatopoetischen Stammzelle, welche typischerweise mit…”
Get full text

Standardized Monitoring of cytomegalovirus-specific Cellular Immunity can Improve Risk Stratification of Recurrent Cytomegalovirus Reactivation after Hematopoietic Stem Cell Transplantation by Wagner, E, Teschner, D, Wolschke, C, Janson, D, Schafer-Eckart, K, Gartner, J, Mielke, S, Schreder, M, Kobbe, G, Kondakci, M, Hilgendorf, I, von Lilienfeld-Toal, M, Klein, S, Heidenreich, D, Kreil, S, Verbeek, M, Grass, S, Ditschkowski, M, Gromke, T, Koch, M, Lindemann, M, Hunig, T, Schmidt, T, Rascle, A, Guldan, H, Barabas, S, Deml, L, Wagner, R, Wolff, D

Get full text

Comparison of Immune Cell Response to Cytomegalovirus Proteins Versus Peptides using an IFN-γ Elispot Assay to Monitor cytomegalovirus-specific Immunity after Hematopoietic Stem Cell Transplantation by Wagner, E, Teschner, D, Wolschke, C, Janson, D, Schafer-Eckart, K, Gartner, J, Mielke, S, Schreder, M, Kobbe, G, Kondakci, M, Hilgendorf, I, von Lilienfeld-Toal, M, Klein, S, Heidenreich, D, Kreil, S, Verbeek, M, Grass, S, Ditschkowski, M, Gromke, T, Koch, M, Lindemann, M, Hunig, T, Schmidt, T, Rascle, A, Guldan, H, Barabas, S, Deml, L, Wagner, R, Wolff, D

Get full text

PF311 ISOLATED PRIMARY ADRENAL LYMPHOMA (IPAL) ‐ AN EMERGING LYMPHOMA ENTITY? RESULTS OF A RETROSPECTIVE MULTICENTER STUDY by Majidi, F., Martino, S., Kondakci, M., Haase, M., Chortis, V., Arlt, W., Ronchi, C.L., Fassnacht, M., Laurent, C., Petit, J.‐M., Casasnovas, O., Habra, M.A., Kanji, A., Salvatori, R., Ho, A., Spyroglou, A., Beuschlein, F., Villa, D., Limvorapitak, W., Wahlin, B., Gimm, O., Rudelius, M., Schott, M., Germing, U., Haas, R., Gattermann, N.

“…Background: Primary adrenal lymphoma (PAL) is a rare lymphoid malignancy that primarily involves the adrenal gland(s) in patients without a previous history of…”
Get full text

Sequential conditioning in high-risk leukaemia: a single-centre experience in 116 patients by Kobbe, G, Kondakci, M, Czibere, A, Bruns, I, Balleisen, S, Fenk, R, Distelmeier, L, Graef, T, Germing, U, Haas, R

“…Allogeneic stem cell transplantation is a curative therapy for many patients with leukemia. However, patients with high-risk disease as defined by adverse…”
Get full text

Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: A new concept of adjuvant glioma therapy? by Sabel, Michael, Rommel, Frank, Kondakci, Mustafa, Gorol, Marion, Willers, Reinhard, Bilzer, Thomas

“…Background and Objectives Nd:YAG laser‐induced thermo therapy (LITT) of rat brains is associated with blood–brain barrier (BBB) permeability changes. We…”
Get full text

Clinical Validation of a Novel Elispot-Based in Vitro Diagnostic Assay: Monitoring Cytomegalovirus-Specific Cell-Mediated Immunity and Risk Stratification in Hematopoietic Stem Cell Transplant Recipients by Wagner, Eva, Teschner, Daniel, Wolschke, Christine, Janson, Dietlinde, Schaefer-Eckart, Kerstin, Gaertner, Johannes, Mielke, Stephan, Schreder, Martin, Kobbe, Guido, Kondakci, Mustafa, Klein, Stefan, Heidenreich, Daniela, Kreil, Sebastian, Hilgendorf, Inken, von Lilienfeld-Toal, Marie, Verbeek, Mareike, Grass, Sandra, Ditschkowski, Markus, Gromke, Tanja, Koch, Martina, Huenig, Thomas, Lindemann, Monika, Schmidt, Traudel, Rascle, Anne, Guldan, Harald, Barabas, Sascha, Deml, Ludwig, Wagner, Ralf, Wolff, Daniel

“…Increasing evidence suggests that impaired cytomegalovirus (CMV)-specific cell-mediated immunity (CMV-CMI) is a major cause of uncontrolled CMV reactivations…”
Get full text

Early Myeloablative Allogeneic Stem Cell Transplantation during High-Dose Cytarabin Induced Cytopenia in Patients with Refractory or Relapsed Myeloid Leukemias by Graef, Thorsten T., Neumann, Frank F., Fenk, Roland R., Kondakci, Mustafa M., Ruf, Lailani L., Steidl, Ulrich U., Haas, Rainer R., Kobbe, Guido G.

“…Allogeneic stem cell transplantation is the most effective therapy for myeloid leukemias. Still, especially patients with refractory disease, unfavourable…”
Get full text